Haemonetics Corp (HAE)

NYSE · Health Care

104.32
+14.05 (+15.56%)
Updated Aug 18, 4:44 PM ET
AI Rating
Buy
Overall Score
72
Trend
75
Momentum
78
Risk
57

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Haemonetics Corp is trading at $104.32, up 15.56% on the session. The 50 day average sits at $78.92 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 70.8, which reads as overbought, and MACD is bullish crossover. Volume is below average.

The nearest support is around $80.83 with resistance near $92.25, so that band frames the current range. Average daily movement is roughly $2.95, or about 2.8% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 75, momentum of 78 and a risk score of 57.

Technical indicators

RSI (14)
70.8
overbought
MACD
3.653
bullish crossover
SMA 20
84.18
SMA 50
78.92
SMA 200
--
unknown
ATR (14)
2.95
avg daily range
Support
80.83
Resistance
92.25
Volume vs 20d
0.71x
below average
Volatility
29.5%
annualised
1 month
+15.67%
3 months
+58.96%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.